-- Medigus Surges Most in Four Months on FDA Approval Request
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-01-25T09:01:06Z
-- http://www.bloomberg.com/news/2012-01-25/medigus-surges-most-in-four-months-on-fda-approval-request.html
Medigus Ltd. (MDGS)  surged the most in more
than four months after the company said it will seek U.S. Food
and Drug Administration approval to market its SRS device for
the treatment of gastro-esophageal reflux disease.  Shares of the maker of endoscopic procedures and devices
rallied 16 percent, the most since Sept. 11, to 0.698 shekel at
10:38 a.m. in  Tel Aviv .  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  